slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 35,071-35,100
Pages 1,379
Rows per page 30
Component
35,071-35,100 of 41,369
11
The slide highlights high-impact clinical trial results presented at two major oncology conferences.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
20
Illustrates the transition from external lab processing to in-house diagnostic capabilities.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
22
Includes references to clinical trials (CheckMate 274, AMBASSADOR, NIAGARA) and drug (Imfinzi).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
24
The slide outlines a hierarchical testing strategy with alpha-exhaustive recycling and gatekeeping.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
26
Includes a table of clinical trial statistics (events, median EFS, HR, P-value) and a risk table.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
28
Includes 'No. of patients at risk' table and statistical summary table.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
32
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
34
The slide uses a market segmentation approach to map clinical trials (NIAGARA, POTOMAC, VOLGA, NILE) to patient populations (NMIBC, MIBC, 1L mUC).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
53
The slide uses a grid layout to categorize clinical trials by disease stage and patient population, highlighting established standards of care (SoC) with hatched patterns.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
09
The slide uses a circular arrow graphic to represent a feedback loop between in-silico and in-vitro processes.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
10
The slide uses a 'How we did it' process flow at the bottom to explain the underlying methodology.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
12
BenevolentAI | Investor Presentation Deck | 31 slidesBenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
13
The slide uses a Gantt-style chart to show the progress of different drug programs. It distinguishes between proprietary (teal) and partner (yellow) pipelines.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
20
The slide uses a vertical list format to present the investment thesis.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
24
The slide uses a split-screen approach to contrast two distinct value drivers: cost reduction and success rate improvement.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
26
The slide outlines a standard clinical trial structure (SAD, Food Effect, MAD) and highlights the competitive advantage of a clean safety profile compared to historical PDE10 inhibitors.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
27
The slide emphasizes the absence of CNS-associated adverse events, which is a key differentiator for this PDE10 inhibitor.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
28
The slide uses a combination of text, scientific charts (dose-response curves), and a process diagram to validate the drug's mechanism.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
29
The slide uses a honeycomb/network diagram to represent data integration and processing.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
07
The chart uses a bar-vertical format to represent GMV growth over time, with callouts for specific events.Delivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations Beat · Problem1 hit
10
The slide uses a simple three-column layout to define the business model pillars.Delivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations Beat · Solution1 hit
14
The table highlights that despite different operational models, the gross profit margins are relatively consistent (7-10%).Delivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations Beat · Solution1 hit
28
The slide uses a stacked bar chart to show the progression of profitability across three business segments over time.Delivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
29
The slide uses a combination of bar charts and a trend line to illustrate financial trajectory.Delivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
27
The slide uses a stacked bar chart to show the transition from negative to positive EBITDA, with a callout box summarizing the group-level ambition.Delivery Hero | Results Presentation Deck | 44 slides · Delivery Hero
Conference presentation Investor relations 1 hit
36
The slide highlights a decrease in 'Other financial assets' due to divestments of minority shareholdings.Delivery Hero | Results Presentation Deck | 44 slides · Delivery Hero
Conference presentation Investor relations 1 hit
09
Includes a callout box for '10 second cycle time'.Eos Energy | Results Presentation Deck | 16 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
The slide uses a funnel-like progression from lead generation to backlog, with specific activities listed for each stage.Eos Energy | Results Presentation Deck | 16 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
The slide uses a comparison framework to justify a merger or partnership by showing how the two entities cover each other's weaknesses.Eutelsat | Investor Presentation Deck | 55 slides · Eutelsat Group
Pitch deck Investor relations Beat · WhatLoop · Golden Circle1 hit
16
The slide uses a series of vertical cards to display specific ESG scores and qualitative performance indicators for each agency.Eutelsat | Investor Presentation Deck | 55 slides · Eutelsat Group
Pitch deck Investor relations 1 hit